- Latest week
- 10 Jul 2026
- Close
- 43.205002
- Fair value
- 49.074432
- Next-week expectancy
- Positive 61.16%
NNO2 Chart Pack
Novo Nordisk A/S
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, NNO2 rose 25.01%, moving from 34.56 to 43.21. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 1.86 and has improved across the 12-week window. Market Dynamics is 1.57 on the latest week. Next-week expectancy is positive at 61.16% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 43.21
- 12-Week Change
- 25.01%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 61.16%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- 1.86
- Market Dynamics
- 1.57
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 43.21
- 12-Week Change
- 25.01%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 61.16%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- 1.86
- Market Dynamics
- 1.57
Over the latest 12 completed weeks ending 2026-07-10, NNO2 rose 25.01%, moving from 34.56 to 43.21. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 1.86 and has improved across the 12-week window. Market Dynamics is 1.57 on the latest week. Next-week expectancy is positive at 61.16% based on similar historical setup states.
Industry Peers
Austria equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| REC Recordati Industria Chimica e Farmaceutica S.p.A. | VIE | 10 Jul 2026 | 51.45 | 51.55 | 51.30 | 51.35 | -0.19% |
| GILD Gilead Sciences, Inc. | VIE | 10 Jul 2026 | 115.30 | 120.24 | 112.12 | 114.86 | -0.38% |
| PFE Pfizer Inc. | VIE | 10 Jul 2026 | 21.29 | 21.36 | 20.73 | 21.20 | -0.40% |
| ROGP ROCHE HOLDING AG PS | VIE | 10 Jul 2026 | 368.00 | 369.00 | 360.00 | 365.00 | -0.82% |
| SANO Sanofi | VIE | 10 Jul 2026 | 76.96 | 77.16 | 74.48 | 76.09 | -1.13% |
| BMYS Bristol-Myers Squibb Company | VIE | 10 Jul 2026 | 50.79 | 50.89 | 49.54 | 50.17 | -1.22% |
| JNJ Johnson & Johnson | VIE | 10 Jul 2026 | 229.75 | 235.05 | 224.65 | 225.80 | -1.72% |
| ROGH Roche Holding AG | VIE | 10 Jul 2026 | 377.20 | 377.20 | 366.40 | 369.60 | -2.01% |
| GRF Grifols, S.A. | VIE | 10 Jul 2026 | 9.12 | 9.12 | 8.90 | 8.92 | -2.13% |
| LLYC Eli Lilly and Company | VIE | 10 Jul 2026 | 1064.20 | 1085.40 | 1037.60 | 1037.60 | -2.50% |
| AMGN Amgen Inc. | VIE | 10 Jul 2026 | 326.70 | 326.95 | 317.60 | 318.25 | -2.59% |
| MRK Merck & Co., Inc. | VIE | 10 Jul 2026 | 113.36 | 114.72 | 108.48 | 108.48 | -4.30% |
| ABBV AbbVie Inc. | VIE | 10 Jul 2026 | 227.70 | 228.00 | 215.60 | 215.60 | -5.31% |
| BAYN Bayer Aktiengesellschaft | VIE | 10 Jul 2026 | 53.64 | 53.76 | 49.49 | 50.18 | -6.45% |
| COPN Cosmo N.V. | VIE | 10 Jul 2026 | 76.40 | 76.40 | 69.50 | 69.50 | -9.03% |
| BIIB Biogen Inc. | VIE | 10 Jul 2026 | 190.60 | 190.96 | 172.66 | 172.66 | -9.41% |